Yongfei Fan
Shanghai, 200331, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung Cancer.
Journal: Nano-micro letters
Published: July 28, 2026
OLR1 as a Key Inflammatory Regulator Associated with Poor Response to Neoadjuvant Immunochemotherapy in Resectable Lung Cancer.
Journal: Journal of inflammation research
Published: May 09, 2026
Toward organ preservation in thoracic malignancies: why interpretable multimodal radiopathomics matters in the neoadjuvant immunotherapy era.
Journal: Journal for immunotherapy of cancer
Published: April 04, 2026
Efficiently enhancing ferroptosis-mediated immunosensitization in lung cancer by an inhalable immune activation nanoplatform.
Journal: Materials today. Bio
Published: September 13, 2025
Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung Cancer.
Journal: Nano-micro letters
Published: August 15, 2025
Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patients.
Journal: NPJ digital medicine
Published: July 17, 2025
HDAC1 Mediates Immunosuppression of the Tumor Microenvironment in Non-Small Cell Lung Cancer.
Journal: Journal of inflammation research
Published: November 29, 2024
Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy.
Journal: Journal of nanobiotechnology
Published: June 21, 2024
Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Journal: Frontiers in endocrinology
Published: July 21, 2023
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer.
Journal: Journal of inflammation research
Published: July 21, 2022
Last Updated: 09/26/2026